Scott Tomlins, MD, PhD

Scott A. Tomlins, M.D., Ph.D., obtained his M.D. and Ph.D. at the University of Michigan Medical School (UMMS). His thesis, completed under the mentorship of Arul Chinnaiyan, M.D., Ph.D., described the identification and characterization of recurrent ETS gene fusions in prostate cancer. He completed residency in Anatomic Pathology at the University of Michigan Health System in June 2012 and is an Assistant Professor of Pathology and Urology, and a member of the Michigan Center for Translational Pathology (MCTP) at UMMS. Dr.

Ivan Maillard, MD, PhD

Ivan Maillard’s main interest is to investigate the signals regulating the development and function of blood-forming stem cells. He studies the specialized microenvironment that nurtures blood-forming stem cells, using the mouse as a model organism.

David Lombard, M.D., Ph.D.

Dr. Lombard received a Ph.D. in Biology from Massachusetts Institute of Technology (2000) and an M.D. from Harvard Medical School (2001). He completed residency training in Anatomic Pathology (2001-2003) at Brigham and Women's Hospital in Boston. Following residency training Dr. Lombard joined the laboratory of Professor Frederick Alt at Children's Hospital as a Posdoctoral Fellow. He continued in this role until joining the faculty of the Department of Pathology in September 2008.

Kate Barald, Ph.D.

Kate Barald received a Ph.D. in Oncology, Immunology and Molecular Biology at McArdle Laboratory for Cancer Research at the University of Wisconsin, Madison in 1974 (mentor: J.F. Perdue). After postdoctoral fellowships at UCSD (sponsored by an MDA postdoctoral fellowship and an NIH NRSA) and Stanford (also sponsored by an NIH NRSA), Barald joined the faculty at the University of Michigan in 1981. She is the Director of the NIH PREP post-baccalaureate program and director of research responsibility and ethics training in the STEM disciplines.

Thomas Wilson, M.D., Ph.D.

Dr. Wilson received his MD PhD from Washington University in St. Louis in 1994, where he studied mechanisms of DNA binding by transcription factors with Dr. Jeffrey Milbrandt. He continued at Washington University to complete residency training in Clinical Pathology, as well as a postdoctoral fellowship in DNA repair with Dr. Michael Lieber. Dr. Wilson joined the faculty at the University of Michigan in 1999 and now holds the rank of Professor. Dr. Wilson pursues basic research into molecular mechanisms of DNA repair and associated mutagenesis in the germline and cancer genomes.

Max Wicha, M.D.

As founding director of the UM Comprehensive Cancer Center, Dr. Wicha is responsible for coordinating all cancer activities related to research and patient care.  Dr. Wicha is nationally known for his research in the field of breast oncology. His lab was part of the team that first discovered stem cells in breast cancer, the first described in any human solid tumor.  Since then, Dr. Wicha has become one of the leading experts on cancer stem cells. Dr. Wicha is also active as a clinician, specializing in the treatment of breast cancer patients.